FDA Safety Changes: Remicade and Doribax - Medscape

FDA Safety Changes: Remicade and Doribax Medscape Infliximab intravenous infusion is indicated for the treatment of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, and ulcerative colitis. On April 16, the FDA approved safety labeling revisions for ...